关注
Jill A. Fisher
标题
引用次数
引用次数
年份
Benefits of ‘observer effects’: lessons from the field
T Monahan, JA Fisher
Qualitative Research 10 (3), 357-376, 2010
4642010
Medical research for hire: the political economy of pharmaceutical clinical trials
JA Fisher
Rutgers University Press, 2009
3452009
Challenging Assumptions About Minority Participation in US Clinical Research
JA Fisher, CA Kalbaugh
American journal of public health 101 (12), 2217-2222, 2011
3212011
Tattooing the body, marking culture
JA Fisher
Body & society 8 (4), 91-107, 2002
3202002
Tracking the social dimensions of RFID systems in hospitals
JA Fisher, T Monahan
International journal of medical informatics 77 (3), 176-183, 2008
3142008
Treatment of overactive bladder in women
KE Hartmann, ML McPheeters, DH Biller, RM Ward, JN McKoy, ...
Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews …, 2009
1832009
Strategies for Obtaining Access to Secretive or Guarded Organizations
T Monahan, JA Fisher
Journal of Contemporary Ethnography 44 (6), 709-736, 2015
1452015
Expanding the Frame of "Voluntariness" in Informed Consent: Structural Coercion and the Power of Social and Economic Context
JA Fisher
Kennedy Institute of Ethics Journal 23 (4), 355-379, 2013
1232013
Evaluation of real-time location systems in their hospital contexts
JA Fisher, T Monahan
International Journal of Medical Informatics 81 (10), 705-712, 2012
1192012
Co‐ordinating ‘ethical’ clinical trials: the role of research coordinators in the contract research industry
JA Fisher
Sociology of health & illness 28 (6), 678-694, 2006
882006
Coming soon to a physician near you: Medical neoliberalism and pharmaceutical clinical trials
JA Fisher
Harvard health policy review 8 (1), 61, 2007
792007
“Ready-to-recruit” or “ready-to-consent” populations? Informed consent and the limits of subject autonomy
JA Fisher
Qualitative Inquiry 13 (6), 875-894, 2007
772007
Indoor positioning and digital management: Emerging surveillance regimes in hospitals
JA Fisher
Surveillance and security: Technological politics and power in everyday life …, 2006
712006
Peering into the pharmaceutical “pipeline”: investigational drugs, clinical trials, and industry priorities
JA Fisher, MD Cottingham, CA Kalbaugh
Social Science & Medicine 131, 322-330, 2015
642015
Ethics of treatment interruption trials in HIV cure research: addressing the conundrum of risk/benefit assessment
GE Henderson, HL Peay, E Kroon, RJ Cadigan, K Meagher, T Jupimai, ...
Journal of medical ethics 44 (4), 270-276, 2018
632018
Procedural misconceptions and informed consent: insights from empirical research on the clinical trials industry
JA Fisher
Kennedy Institute of Ethics Journal 16 (3), 251-268, 2006
592006
Adverse Events: Race, Inequality, and the Testing of New Pharmaceuticals
JA Fisher
New York University Press, 2020
582020
Feeding and bleeding: The institutional banalization of risk to healthy volunteers in phase I pharmaceutical clinical trials
JA Fisher
Science, Technology, & Human Values 40 (2), 199-226, 2015
542015
‘I'm still a hustler’: entrepreneurial responses to precarity by participants in phase I clinical trials
T Monahan, JA Fisher
Economy and Society 44 (4), 545-566, 2015
522015
Sex, gender, and pharmaceutical politics: from drug development to marketing
JA Fisher, LM Ronald
Gender medicine 7 (4), 357-370, 2010
512010
系统目前无法执行此操作,请稍后再试。
文章 1–20